Becker Muscular Dystrophy - 196 Studies Found
Withdrawn |
: Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Therapy for Patients With Duchenne Muscular Dystrophy : Duchenne Muscular Dystrophy : 2012-05-21 : Biological: human umbilical cord mesenchymal stem cells rehabilitation therapy plus human umbilical cord |
Recruiting |
: An Extension Study to Assess Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD) : Duchenne Muscular Dystrophy : 2016-04-28 :
|
Recruiting |
: A Study to Assess Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD) : Duchenne Muscular Dystrophy : 2016-04-28 :
|
Enrolling by invitation |
: Long-term Extension Study to Assess Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD) : Duchenne Muscular Dystrophy : 2017-01-30 :
|
Active, not recruiting |
: Dose-Titration and Open-label Extension Study of SRP-4045 in Advanced Stage Duchenne Muscular Dystrophy (DMD) Patients : Duchenne Muscular Dystrophy : 2015-08-10 :
|
Completed |
: Stem Cell Therapy in Duchenne Muscular Dystrophy : Duchenne Muscular Dystrophy : 2014-09-12 : Biological: Stem Cell Intrathecal autologous bone marrow mononuclear cell transplantation |
Completed |
: Safety Study of Flavocoxid in Duchenne Muscular Dystrophy : Duchenne Muscular Dystrophy : 2011-04-12 : Drug: Flavocoxid Flavocoxid capsules TTD 500 mg/die or 1000 mg/die for 1 year |
Active, not recruiting |
: Sunphenon Epigallocatechin-Gallate (EGCg) in Duchenne Muscular Dystrophy : Duchenne Muscular Dystrophy : 2010-08-17 :
|
Completed |
: Eplerenone for Subclinical Cardiomyopathy in Duchenne Muscular Dystrophy : Duchenne Muscular Dystrophy : 2012-01-26 :
|
Recruiting |
: Study of DS-5141b in Patients With Duchenne Muscular Dystrophy : Duchenne Muscular Dystrophy : 2016-01-26 : Drug: DS-5141b DS-5141b, Subcutaneous injection |